AU2011100568A4 - Herbal compositions and uses for the maintenance of normal glucose levels and general well-being - Google Patents
Herbal compositions and uses for the maintenance of normal glucose levels and general well-being Download PDFInfo
- Publication number
- AU2011100568A4 AU2011100568A4 AU2011100568A AU2011100568A AU2011100568A4 AU 2011100568 A4 AU2011100568 A4 AU 2011100568A4 AU 2011100568 A AU2011100568 A AU 2011100568A AU 2011100568 A AU2011100568 A AU 2011100568A AU 2011100568 A4 AU2011100568 A4 AU 2011100568A4
- Authority
- AU
- Australia
- Prior art keywords
- maintenance
- herbs
- general well
- mammals
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 238000012423 maintenance Methods 0.000 title claims abstract description 19
- 230000036642 wellbeing Effects 0.000 title claims abstract description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 9
- 239000008103 glucose Substances 0.000 title abstract description 9
- 235000008216 herbs Nutrition 0.000 claims abstract description 24
- 241000124008 Mammalia Species 0.000 claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 244000241838 Lycium barbarum Species 0.000 claims description 8
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 8
- 244000302512 Momordica charantia Species 0.000 claims description 8
- 235000009811 Momordica charantia Nutrition 0.000 claims description 8
- 241000723347 Cinnamomum Species 0.000 claims description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 4
- 235000021511 Cinnamomum cassia Nutrition 0.000 claims description 4
- 235000005903 Dioscorea Nutrition 0.000 claims description 4
- 244000281702 Dioscorea villosa Species 0.000 claims description 4
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 4
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 4
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 4
- 241000972673 Phellodendron amurense Species 0.000 claims description 4
- 244000197580 Poria cocos Species 0.000 claims description 4
- 235000008599 Poria cocos Nutrition 0.000 claims description 4
- 241000405911 Rehmannia glutinosa Species 0.000 claims description 4
- 235000017803 cinnamon Nutrition 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- -1 Chromium picolinate Zinc citrate Magnesium citrate Chemical compound 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 abstract description 16
- 206010022489 Insulin Resistance Diseases 0.000 abstract description 6
- 230000015556 catabolic process Effects 0.000 abstract description 6
- 230000004190 glucose uptake Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 239000012676 herbal extract Substances 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000012674 herbal formulation Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940046374 chromium picolinate Drugs 0.000 description 2
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960005336 magnesium citrate Drugs 0.000 description 2
- 235000002538 magnesium citrate Nutrition 0.000 description 2
- 239000004337 magnesium citrate Substances 0.000 description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Abstract The present innovation relates generally to a composition for the regulation of body sugar levels, such as but not limited to providing regulation of sugar metabolism, increasing muscle glucose uptake, breakdown and energy production, improving insulin sensitivity and increasing the transport of glucose into cells, and supporting the maintenance of general well-being in mammals. More particularly, the present innovation is directed to compositions comprising herbs or extracts of herbs or botanical or horticultural equivalents of the herbs or chemical or functional equivalents of the herbal extracts useful for the regulation of body sugar levels, such as but not limited to providing regulation of sugar metabolism, increasing muscle glucose uptake, breakdown and energy production, improving insulin sensitivity and increasing the transport of glucose into cells, and supporting the maintenance of general well-being in mammals. The present innovation further contemplates a method of uses in mammals by administration of a herbal composition or its chemical or functional equivalent in the maintenance of normal body sugar levels and general well-being.
Description
Specification of GlucoPia Capsule Applicants: Guorang Hu, Wangcheng Hu, and G & W Aust Pty Ltd Country: Australia Application: Australian Innovation Patent Title: Herbal compositions and uses for the maintenance of normal glucose levels and general well-being Field of Innovation The present innovation relates generally to a composition for the regulation of body sugar levels, such as but not limited to providing regulation of sugar metabolism, increasing muscle glucose uptake, breakdown and energy production, improving insulin sensitivity and increasing the transport of glucose into cells, and supporting the maintenance of general well-being in mammals. More particularly, the present innovation is directed to compositions comprising herbs or extracts of herbs or botanical or horticultural equivalents of the herbs or chemical or functional equivalents of the herbal extracts useful for the regulation of body sugar levels, such as but not limited to providing regulation of sugar metabolism, increasing muscle glucose uptake, breakdown and energy production, improving insulin sensitivity and increasing the transport of glucose into cells, and supporting the maintenance of general well-being in mammals. The present innovation further contemplates a method of uses in mammals by administration of a herbal composition or its chemical or functional equivalent for the maintenance of normal glucose levels and general well-being. Background of the Innovation Herbal formulations comprising extracts of more than one herbal plant have been used for centuries in Traditional Chinese Medicine (TCM). Use of herbal formulations is a major principle of TCM in the utilization of herbs in the management of diseases. There is now an increasing acceptance of their value and therapeutic efficacy in Western medicine. TCM has its unique and philosophical theory in etiology, diagnosis, pharmacology and therapeutics. In fact, many concepts surrounding TCM have particular relevance to Western medicine such as viewing parts of the body as an organic whole, considering inter-relations and influences between organs and being aware of relevant adaptation of the human body to the natural environment. As such, integration of ancient wisdom and modern sciences in herbal formulations has become a valuable approach to the research and development of useful herbal preparations in the management of sub-optimal and chronic health conditions. Both applicants of this Innovation are senior medical doctors and have long been practising TCM and are experienced in the treatment of the age-related and sub-optimal health disorders. One of the applicants of this Innovation, Dr. GR Hu has twenty years of research study experiences at the University of Sydney and more than 40 years of clinical practice in herbal medicines, and also been granted PhD in medicine in TCM clinical research at the Department of Medicine, the University of Sydney. Combined with the latest scientific findings and modern pharmaceutical technology, the applicants have developed a series of leading edge herbal medications in the fields of ageing, allergies, arthritis, male function, and regulation of sugar and cholesterol, in which one has been internationally patented in the US, Singapore, China and Australia, another six have been granted Innovation patents. Now a new formulation for the regulation of body sugar levels and supporting the maintenance of general well-being in mammals has been developed, and lead up to the present innovation patent application. This Innovation is developed upon a latest scientifically formulated herbal formulation by the applicants for the regulation of body sugar levels and supporting the maintenance of general well-being in mammals. The herbs in this formula have long been used as traditional medicines for the symptomatic relief of diabetes and maintenance of general well-being. Extensive research has shown that the main active components of these herbs are effective in the regulation of body sugar levels, increasing muscle glucose uptake, breakdown and energy production, improving insulin sensitivity and increasing the transport of glucose into cells, and supporting the maintenance of general well-being in mammals. Summary of the innovation One aspect of the present innovation provides a composition comprising herbs or extracts of herbs or botanical or horticultural equivalents of herbs or chemical or functional equivalents of the extract wherein said composition is effective for the regulation of body sugar levels, such as but not limited to providing regulation of sugar metabolism, increasing muscle glucose uptake, breakdown and energy production, improving insulin sensitivity and increasing the transport of glucose into cells, and supporting the maintenance of general well-being in mammals. A further aspect of the present innovation provides a composition comprises four or more herbs or extracts of four or more herbs selected from the list comprising: Phellodendron amurense bark Lycium barbarum (Goji berry) fruit Momordica charantia (Bitter melon) fruit Rehmannia glutinosa rhizome Cinnamomum cassia (Cinnamon) stem bark Dioscorea opposite rhizome Poria cocos herb Comus officinalis fruit Paeonia suffruticosa root bark Chromium picolinate Zinc citrate Magnesium citrate Another aspect of the present innovation contemplates a method of oral use in mammals by administration of a herbal composition or its chemical or functional equivalent for the regulation of body sugar levels and supporting the maintenance of general well-being in mammals, and the said method comprising administering an effective amount of the composition as hereinbefore described for a time and under conditions sufficient for the regulation of body sugar levels, and supporting the maintenance of general well-being in mammals. Detailed description of the preferred embodiments In a most preferred embodiment, the composition comprises the following herbs or extracts thereof in approximate percentage amounts shown in parentheses: Name Ingredient Amount Information (%, W/W) Phellodendron amurense Bark, Dry 5-60 Lycium barbarum (Goji berry) Fruit, Dry 5-50 Momordica charantia (Bitter melon) Fruit, Dry 5-50 Rehmannia glutinosa Rhizome, Dry 5-30 Cinnamomum cassia (Cinnamon) Stem bark, Dry 2-30 Dioscorea opposite Rhizome, Dry 2-30 Poria cocos Herb, Dry 2-20 Comus officinalis Fruit, Dry 2-20 Paeonia suffruticosa Root bark, Dry 2-20 Chromium picolinate Powder, Dry 0.01-2 Zinc citrate Powder, Dry 0.01-5 Magnesium citrate Powder, Dry 0.01-5 The compositions of the present innovation may also comprise one or more pharmacologically acceptable carriers and/or diluents. Such carriers and/or diluents include any and all solvents, water, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption or penetration enhancing agents and the like. Preferably, the diluent is water or a water or alcohol based extraction of the herbs. The composition may be in the form of capsules, tablets, buccal tablets, troches, elixirs, suspensions, syrups, wafers, plaster, cream and the like. They may also be in a form which may be inhaled or given by nasal spray, aerosol droplets or vapour infusion. Particularly important conditions to treat are the maintenance of normal body sugar levels, and support of the general well-being in mammals. In a particularly preferred embodiment, the herbs are contained and subject to conventional extraction techniques. Such techniques include water extraction, solvent extraction, alcohol extraction and/or acid or base extraction. The resulting extract is then preferably incorporated into a capsule. Mammals contemplated herein include humans, primates, laboratory test animals (eg. mice, rabbits, guinea pigs, hamsters), livestock animals (eg. cows, sheep, horses, pigs), companion animals (eg. dogs, cats) or captive wild animals. Preferably, the mammal is a human. Preferably, the compositions are provided orally such as in capsule forms, where multiple capsules are performed hourly, daily, weekly or monthly. Example 1 The GlucoPia Capsule herbal formulation comprises extracts from nine herbs and three minerals. The herbs and minerals employed and their percentage amounts are shown in Table 1.
Table 1 NeuroZeal Capsule herbal formulation Name Ingredient % Amount Information (w/w) Phellodendron amurense Bark, Dry 50.68 Lycium barbarum (Goji berry) Fruit, Dry 14.08 Momordica charantia (Bitter melon) Fruit, Dry 10.56 Rehmannia glutinosa Rhizome, Dry 7.04 Cinnamomum cassia (Cinnamon) Stem bark, Dry 3.52 Dioscorea opposite Rhizome, Dry 3.52 Poria cocos Herb, Dry 3.52 Comus officinalis Fruit, Dry 3.52 Paeonia suffruticosa Root bark, Dry 3.52 Chromium picolinate Powder, Dry 0.01 Zinc citrate Powder, Dry 0.02 Magnesium citrate Powder, Dry 0.03 Example 2 Herbal extraction techniques were performed according to specific protocols and were designed to maintain maximal levels of active components. Extracts of the nine herbs and three minerals listed in Table 1 were formulated and capsulated, then sealed in bottles.
Claims (4)
1. A composition comprising herbs or extracts of herbs or botanical or horticultural equivalents of herbs or chemical or functional equivalents of the extract wherein said composition is effective for the maintenance of normal body sugar levels, and support of the general well being in mammals.
2. A composition according to claim 1 comprises the following herbs: Phellodendron amurense bark Lycium barbarum (Goji berry) fruit Momordica charantia (Bitter melon) fruit Rehmannia glutinosa rhizome Cinnamomum cassia (Cinnamon) stem bark Dioscorea opposite rhizome Poria cocos herb Comus officinalis fruit Paeonia suffruticosa root bark Chromium picolinate Zinc citrate Magnesium citrate
3. A method according to claim 1 for the maintenance of normal body sugar levels, and support of the general well-being in mammals.
4. The said method comprising administering an effective amount of the composition as hereinbefore described for a time and under conditions sufficient to help said the maintenance of normal body sugar levels, and support of the general well-being in mammals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011100568A AU2011100568A4 (en) | 2011-05-18 | 2011-05-18 | Herbal compositions and uses for the maintenance of normal glucose levels and general well-being |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011100568A AU2011100568A4 (en) | 2011-05-18 | 2011-05-18 | Herbal compositions and uses for the maintenance of normal glucose levels and general well-being |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2011100568A4 true AU2011100568A4 (en) | 2011-06-23 |
Family
ID=45398548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011100568A Ceased AU2011100568A4 (en) | 2011-05-18 | 2011-05-18 | Herbal compositions and uses for the maintenance of normal glucose levels and general well-being |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2011100568A4 (en) |
-
2011
- 2011-05-18 AU AU2011100568A patent/AU2011100568A4/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011100558A4 (en) | Herbal compositions and uses for symptomatic relief of tinnitus, migraine, headaches, vertigo, insomnia and sleeplessness | |
| Mensah et al. | Toxicity and Safety Implications of Herbal Medicines | |
| Soni et al. | Pharmacological properties of Datura stramonium L. as a potential medicinal tree: an overview | |
| Sher et al. | Indigenous knowledge of folk medicines among tribal minorities in Khyber Pakhtunkhwa, northwestern Pakistan | |
| Ouachrif et al. | Comparative study of the anti-inflammatory and antinociceptive effects of two varieties of Punica granatum | |
| Aja et al. | Evaluation of anti-diabetic effect and liver enzymes activity of ethanol extract of Pterocarpus santalinoides in alloxan induced diabetic albino rats | |
| Wanjari et al. | An overview on herbal medicine | |
| Li et al. | Policies and problems of modernizing ethnomedicine in China: A focus on the yi and dai traditional medicines of yunnan province | |
| Upendra et al. | Healthcare prominence and immune boosting activity of ashwagandha against various clinical conditions and covid 19 disease outbreak | |
| Tepongning et al. | Potential of a Khaya ivorensis–Alstonia boonei extract combination as antimalarial prophylactic remedy | |
| Yarnell et al. | Dilemmas of Traditional Botanical Research. | |
| Mohammed et al. | Anti-hyperglycaemic and selected organ protective effects of Ziziphus spina-christi hydroethanol leaf extract in alloxan induced diabetic rats | |
| AU2009101062A4 (en) | Herbal compositions and oral uses for relief of arthritic pain and joint inflammation | |
| AU2009101063A4 (en) | Herbal compositions and uses for male support, male well-being, sexual performance and normal sexual libido | |
| AU2007100050A4 (en) | Herbal compositions and uses for vitality-boosting in aging and sub-optimal health | |
| Njan | Herbal medicine in the treatment of malaria: Vernonia amygdalina: an overview of evidence and pharmacology | |
| JP7523889B2 (en) | Pharmaceutical composition for improving activity level | |
| AU2011100568A4 (en) | Herbal compositions and uses for the maintenance of normal glucose levels and general well-being | |
| Rafi et al. | Acmella calva (DC.) RK Jansen Flower: A Comprehensive In vivo Study of its Central and Peripheral Analgesic, Hypoglycemic, Antidepressant, and Anti-Diarrheal Properties | |
| Chen et al. | Anti-fatigue effect of aqueous extract of Anisomeles indica (L) Kuntze in mice | |
| Yadav et al. | Looking Forward to the Promising Anti-Filarial Plant Resources and Futuristic Drug Discovery Approaches | |
| AU2007101169A4 (en) | Herbal compositions and uses for maintaining normal healthy cholesterol levels, supporting a healthy ratio of HDL/LDL, as well as enhancing general health in aging | |
| Kaur et al. | Species of the Berberis genus found in the Western Himalayas | |
| Ogbiko et al. | Phytochemical composition, acute toxicity and lipid profile of the methanol leaf extract of Piliostigma Thonningii (Fabaceae) | |
| AU2013101104A4 (en) | Herbal compositions and uses for symptomatic relief of cardiovascular diseases and helping maintain normal healthy cardiovascular and heart function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGI | Letters patent sealed or granted (innovation patent) | ||
| MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |